{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["207(4)"],"submitter":["Bashy B"],"journal":["British journal of haematology"],"pagination":["1659-1663"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC12512062"],"repository":["biostudies-literature"],"pubmed_title":["Differences in adverse events between manuscript and drug labels for myeloma T-cell-redirecting therapies."],"pmcid":["PMC12512062"],"pubmed_authors":["Bashy B","Steensma D","Van Oekelen O","Shah D","Chakraborty R","Mohyuddin GR"],"additional_accession":[]},"is_claimable":false,"name":"Differences in adverse events between manuscript and drug labels for myeloma T-cell-redirecting therapies.","description":null,"dates":{"release":"2025-01-01T00:00:00Z","publication":"2025 Oct","modification":"2026-06-04T07:04:31.559Z","creation":"2026-05-06T03:13:05.7Z"},"accession":"S-EPMC12512062","cross_references":{"pubmed":["40923801"],"doi":["10.1111/bjh.70042"]}}